{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:52:07Z","timestamp":1786121527074,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Difficult-to-treat (DTT) psoriatic arthritis (PsA) is characterized by persistent disease activity despite treatment with multiple advanced therapies. Angiogenesis and extracellular matrix remodeling are key processes in chronic inflammatory arthritis, with CD147 acting as an important regulator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our aim was to evaluate the circulating pro- and anti-angiogenic mediators and inflammatory cytokines in patients with DTT PsA compared with non-DTT PsA controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Serum samples from 22 patients with DTT PsA were compared with matched samples from 25 non-DTT PsA patients who were on biologics or targeted therapies (non-DTT Bio) and with 25 non-DTT PsA patients who were naive to biologics and targeted therapies and received conventional disease-modifying antirheumatic drugs (cDMARDs) or non-steroidal anti-inflammatory drugs (NSAIDs) (non-DTT cDMARDs). The concentrations of angiogenic factors and inflammatory cytokines were determined with ELISA. Compared with both control groups, patients with DTT PsA demonstrated significantly higher serum levels of CD147 and increased activities of MMP-9 and proteasome 20S, which were measured by the cleavage of their respective fluorescent substrates. The levels of vascular endothelial growth factor (VEGF), TIMP-1, endostatin, and thrombospondin-1 (Tsp-1) did not differ significantly. The scratch assay with diluted serum samples, which was used to measure the ability of endothelial cells to migrate and close the gap, revealed enhanced angiogenic potential in the DTT group relative to the two control groups. In contrast, no differences between the groups were revealed in the serum levels of IL-17, IL-23, IL-22, IL-6, TNF-\u03b1, and TGF-\u03b2, and only IL-12p70 was reduced in the DTT relative to the control groups. The CD147 levels increased over time exclusively in the DTT PsA group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An enhanced angiogenic profile, highlighted by an elevated CD147, was found in patients with DTT PsA compared with non-DTT patients, requiring further studies to better understand its role in the pathogenesis of and as a biomarker in PsA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1873191","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:29:38Z","timestamp":1786080578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiogenic markers in difficult-to-treat psoriatic arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Amir","family":"Haddad","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Simanovich","sequence":"additional","affiliation":[{"name":"Immunotherapy Laboratory, Carmel Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunia","family":"Araide","sequence":"additional","affiliation":[{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nili","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Clalit Health Services","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Hayat","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Milman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Gazitt","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Feld","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muna","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal A.","family":"Rahat","sequence":"additional","affiliation":[{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]},{"name":"Immunotherapy Laboratory, Carmel Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Carmel Medical Center","place":["Haifa, Israel"]},{"name":"Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf207","article-title":"Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis","volume":"64","author":"Ribeiro","year":"2025","journal-title":"Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/2045-824X-5-11","article-title":"Macrophages and angiogenesis in rheumatic diseases","volume":"5","author":"Maruotti","year":"2013","journal-title":"Vasc Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02333-6","article-title":"The role of EMMPRIN\/CD147 in regulating angiogenesis in patients with psoriatic arthritis","volume":"22","author":"Rahat","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1186\/ar575","article-title":"Angiogenesis in rheumatoid arthritis","volume":"4","author":"Paleolog","year":"2002","journal-title":"Arthritis Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e00283","DOI":"10.1042\/BSR20150256","article-title":"How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity","volume":"36","author":"Grass","year":"2016","journal-title":"Biosci Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202518884","article-title":"CD147\/Basigin: From integrative molecular hub to translational therapeutic target","volume":"13","author":"Yang","year":"2025","journal-title":"Adv Sci"},{"key":"B8","article-title":"Cancer-related issues of CD147","volume":"7","author":"Weidle","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1247\/csf.25.97","article-title":"Collagen XVIII\/Endostatin structure and functional role in angiogenesis","volume":"25","author":"Zatterstrom","year":"2000","journal-title":"Cell Struct Funct"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1319939","article-title":"Soluble CD147 regulates endostatin via its effects on the activities of MMP-9 and secreted proteasome 20S","volume":"15","author":"Rahat","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14305","article-title":"Role of soluble CD147 in psoriatic patients: a preliminary study","volume":"45","author":"Gao","year":"2018","journal-title":"J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","article-title":"Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment","volume":"69","author":"Coates","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B13","article-title":"Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review","volume":"33","author":"Smolen","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.084244","article-title":"Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index","volume":"68","author":"Maksymowych","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B15","article-title":"Development of an assessment tool for dactylitis in patients with psoriatic arthritis","volume":"32","author":"Helliwell","year":"2005","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232565","article-title":"An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137267","article-title":"Tofacitinib regulates endostatin via effects on CD147 and cathepsin S","volume":"25","author":"Zisman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1136\/rmdopen-2023-003809","article-title":"Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project","volume":"10","author":"Singla","year":"2024","journal-title":"RMD Open"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1238051","article-title":"CD147: an integral and potential molecule to abrogate hallmarks of cancer","volume":"13","author":"Nyalali","year":"2023","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739592","article-title":"Tocilizumab (TCZ) decreases angiogenesis in rheumatoid arthritis through its regulatory effect on miR-146a-5p and EMMPRIN\/CD147","volume":"12","author":"Zisman","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"739592","DOI":"10.3390\/cancers11111803","article-title":"CD147 is a promising target of tumor progression and a prognostic biomarker","volume":"11","author":"Landras","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/ijms262210850","article-title":"Dual roles of CD147 in regulating THP-1 monocyte migration and MCP-1-induced inflammatory responses","volume":"26","author":"Intasai","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B23","article-title":"Extracellular matrix metalloproteinase inducer enhances host resistance against pseudomonas aeruginosa infection through MAPK signaling pathway","volume":"8","author":"Li","year":"2016","journal-title":"Am J Transl Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873191\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:29:39Z","timestamp":1786080579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873191\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2026.1873191"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1873191","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1873191"}}